pTVG-HP
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for pTVG-HP, covering 2023-12-06 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC [Phase 1]